Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
10.1093/toxsci/kfj111 63 KlicekR.KolencD.SuranJ.DrmicD.BrcicL.AralicaG.et al (2013)
The results showed that the weight reduction effect of the drug was not attenuated at 52 weeks in either subgroup [for Asian patients 3 mg: WMD 0.35, P = 0.29 (two studies)
The drug is only approved for weight loss in people with a body mass index over 30, or over 25 with another condition like type 2 diabetes or high cholesterol
Key Takeaways Semaglutide is not directly linked to insomnia, and reported sleep issues occur at similar rates as placebo in clinical studies
GLP-1 receptor agonists are a class of medications originally developed to lower blood sugar in people with type 2 diabetes
US$ 21.88
US$ 25.30
US$ 21.87
US$ 28.73
US$ 26.42
US$ 21.60
